Testing effectiveness (Phase 2)Ended earlyNCT02167451
What this trial is testing
Maraviroc as GVHD Prophylaxis in Transplant Recipients
Who this might be right for
Diagnoses That Require Stem Cell TransplantGraft Versus Host Disease (GVHD)
Children's Hospital Medical Center, Cincinnati 31